Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05964413
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2023-06-29
Brief Title:
Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum
Sponsor:
InflaRx GmbH
Organization:
InflaRx GmbH
Organization Data
Organization:
InflaRx GmbH
Class:
INDUSTRY
Study ID:
IFX-1-P34
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
InflaRx GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None